United States: Supreme Court Declines To Hear Idenix Case: Dispute Surrounding The Enablement Standard For Biotechnology Patents Continues - Oblon, McClelland, Maier & Neustadt, L.L.P
On January 19, 2021, the Supreme Court denied a petition for certiorari to hear the Idenix Pharmaceuticals LLC v. Gilead Sciences Inc. case (941 F.3d 1149 (Fed. Cir. 2019)).
Full Article